Tag: remission

Biomarker, Innovation

Early study finds new lymphoma drug effective

May 13, 2022

Via: ScienceDaily

In early research led by the University of Michigan Health Rogel Cancer Center, the oral medication zanubrutinib was found to help most patients with a slow-growing type of cancer known as marginal zone lymphoma. Cancers shrunk in 80% of the […]

Biomarker, Innovation

Clinical Challenges: Discontinuing TKIs in Chronic Myeloid Leukemia

December 11, 2020

Via: MedPageToday

Treatment-free remission is now regarded as a primary aim of patients with long-term chronic myeloid leukemia (CML). Starting with the approval of imatinib in 2001, the effectiveness of tyrosine kinase inhibitors (TKIs) has resulted in significant improvements in outcomes for […]

Innovation, Research

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

October 4, 2018

Via: The Medical News

New research presented at this year’s annual meeting of the European Association for the Study of Diabetes (EASD) in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the […]